|
 |
| home > ict > Summer 2007 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT |
 |
| |
|
|
|
| The heavy economic burden on health resources caused by adverse drug reactions means that the importance of drug safety cannot be overstated. In Not Just a Phase, Stuart Mair at Charles River Laboratories Clinical Services says the proof is in the planning and design during early drug development |
|
|
| In Image Conscious, Gunter Bellaire of Perceptive Informatics reflects on the features of a centralised imaging review in multicentre trials – a process driving forward the standardisation of image acquisition and independence from clinical patient information – that supports the objectivity of image analysis |
|
|
| Get research right, and not only will it allow you to designate recruitment tactics customised to the specific needs of each country, but it will also inform the cultural adaptation of the recruitment message. BBK Worldwide’s Elizabeth Gargill gets us Ready to Recruit |
|
|
| Since the mid-1990s, clinical research has expanded rapidly in Central and Eastern Europe. In Going Further East in CEE, Anna Anokhina and Dmitry Meshkov of MQ Quest Inc investigate the status of clinical studies in CEE and assess the mechanisms supporting further development of clinical trials |
|
|
| Faced with a drug development process running over budget and delivering too few approved novel compounds, Tom Parke of Tessella calls for adaptive clinical trials to radically overhaul the whole clinical trial sector, in Value Added Trials |
|
|
|
| Study sites are regularly blamed by the industry for their incomplete knowledge of legal and regulatory requirements, whilst sponsors are accused of using tricky and difficult-to-understand legal jargon. In Building Consensus, Henry Yau at the Clinical Trials Centre proposes clinical trial agreements as a holistic solution to industry conflict |
|
|
|
| Making time and quality improvements, whilst maintaining the integrity of the overall process, are enduring goals for clinical research teams. In an attempt to break the mould, Hui Li and Eva Miller of ALMAC Clinical Technologies discover new ways to leverage resources, in Clinical Teams and Tools |
|
|
| Technology is already playing a pivotal role in facilitating and speeding up both internal and external communication processes. Multi-site and multicountry pharmaceutical organisations are turning to truly global virtual teams to keep up with the pressure to modernise, explains Michael McGrath and Tom O’Leary of ICON, in The Driving Force of Technology |
|
|
| In the past decade CDISC has been developing and establishing standards that facilitate the collection, exchange, reporting and submission of clinical data, whilst formulating standardised terminology for such processes. In The Happy Couple, Katrien Vermeiren of SGS Life Science Services reiterates the benefits of close collaboration between the EDC providers and sponsors |
|
|
| Few dispute that EDC provides real-time access to more accurate data, shortening the clinical trial timeframe and automatically generating some level of cost savings. David Laky of eResearchTechnology, Inc, books an Appointment at the eClinic |
|
|
|
|
| With growth expected within the Asia-Pacific and Latin American regions to be around 40 per cent of clinical trial activities by 2011, Jonathan Blamey and Chris Tierney of DHL Healthcare focus on the key areas for logistics providers offering services for clinical trials, in Part of the Process |
|
|
|
| As cancer clinical research continues to look for better identification of patients who respond to treatment, in Signature Dish, Marc Buyse of the International Drug Development Institute outlines developments in molecular profiling as a targeted therapy for early breast cancer |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
Exploratory Clinical Development World Americas 2008
23-25 September 2008, Philadelphia Marriott Downtown, 1201 Market Street, Philadelphia, Pennsylvania, 19107 USA
Following on from the huge success of the Exploratory
Clinical Development World Europe, the Americas
congress will give you a critical insight into the latest strategies on how the
industry is addressing and elevating the current challenges in early clinical
development.
More info >> |
|
 |
News and Press Releases |
 |
GEMÜ goes to Russia
Moscow, 27th May 2008.
At the opening ceremony the founder of the company and
managing partner, Fritz Müller, gave the starting signal for the new sales and
marketing subsidiary “OOO GEMÜ Russia” which will be managed by Mr Hans-Joachim
Götze. The guests present at the ceremony included the executive board of the
GEMÜ Group and Russian customers. GEMÜ Russia is the 16th sales and
marketing subsidiary in the GEMÜ Group.
More info >> |
|
__________________________
__________________________
__________________________
__________________________
|
